Type III interferons control gasdermin C mediated pyroptosis in the intestine. A masterful study by Zanoni and colleagues. Kudos to the authors on this fascinating discovery. @Lo_Zanzi@harvardmed
https://t.co/WKzBWhQHAc
#CoagulationPower! Stark &co show @ImmunityCP that antigen-independent activities of antibodies drive pathological coagulation! IgM activate endothelial cells that recruit platelets that bind IgG inducing #complement activation, NETosis & thrombosis https://t.co/Q3cSJegKl6
#CoagulationAndImmunity! Ryu, @AkassoglouLab &co show @Nature that the #SARSCoV2 Spike binds & activates #fibrin, driving type I interferon signaling, macrophage activation, NK cell inhibition, & neuroinflammation, independently of infection! #LongCOVID https://t.co/q2PpFnGjEX
A couple recent first edition papers online, each the result of outstanding collaborators - @RondinaLab and @ADJomics - and great students.
https://t.co/5VqD8X2HJx
https://t.co/CgvRgiC56X
Linking the brain's lymphatics to migraine pain
@CaronLabUNC@ManeyNelson and colleagues report a surprising role for lymphatics in chronic migraine and response to anti-migraine therapeutics. https://t.co/bHSy4wGrat
Our study "Iron capture through CD71 drives perinatal and tumor-associated Treg expansion" has just been published in @JCI_insight!
https://t.co/dcU271D17h
#SeeingIsBelieving! Fantastic @Nature by @jkagan1@DanielHFish &co! What we believed it was the #Myddosome is only a piece of a much more complex barrel which structure determines #TLR signaling within the Myddosome via interactions with signaling elements!https://t.co/3L58nXZAWK
Today I had the opportunity to present our latest data on “ironic” #Treg at the @AIRC_it - @IFOMresearch joint meeting. The picture shows “Tregologists” clustering together! Here with the “Master of Tregs” Sasha Rudensky
Congrats first-author @abigailrballard & team at @BergmeierLab who published in @BloodJournal "4D intravital imaging identifies platelets as the predominant cellular procoagulant surface in a mouse hemostasis model" 1/n
I don’t like the term “trainee” because it suggests that at some point the training ends, when really what I love about science is that you keep improving in the art of making discoveries.
The first drug approved for MASH, along with the global toll of this disease, summarized (e.g. ~30% of world population w/ MAFLD)
https://t.co/cTApKmkums
Aging-enriched platelets are functionally hyper-reactive reveling stem cell-based aging as a mechanism for platelet dysregulation & age-induced thrombosis @MHolinstat @CellCellPress .https://t.co/RvLxAgZeO2
Is forgetting a bug or a feature? Can you delay it and remember longer? Our 🥶COOLEST paper to date (and our most poetic abstract…) Show LOVE ❤️and please SHARE! Thread (1/N)👇
https://t.co/nhe4P2dk7G
#GSDMDpower! @YountLabOSU@adforu@samuel_speaks @ZaniAshley @m_mcfadden17 &co show @NatureComms that during influenza A virus infection, GSDMD exacerbates inflammation (without affecting viral levels) via potentiation of neutrophil functions/NETosis!! https://t.co/ydEC4B2PwT